Strona główna・Stock List・Capricor Therapeutics Inc

Capricor Therapeutics Inc

Open

6.18 1.64

Buy Sell

Overview

Share price change

24h

Current

Min

5.73

Max

6.29

Key metrics
By Trading Economics
Income	-6.8M -41M
EPS	-0.7
Employees	231
EBITDA	289M 255M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+342.62% upside

Dividends
By Acuity
Next Earnings	9 lis 2026

Market Stats
By TradingEconomics
Market Cap	111M 334M
Previous open	4.54
Previous close	6.18

Capricor Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

27 paź 2026, 23:56 UTC

Rithm Capital Corp. showed little change in after-market hours, trading lower since Tuesday's close, while remaining above its 20-day moving average.

27 paź 2026, 23:56 UTC

CDW Corporation shares declined in after-market trading, marking a third consecutive session of losses, despite broader market activity and rising durable goods orders in September.

27 paź 2026, 23:56 UTC

News

Rosenblatt downgraded OneSpan Inc. to Neutral while maintaining a price target of $18, contributing to a decline in after-market trading.

27 paź 2026, 23:56 UTC

Norwood Financial Corp's shares have declined in after-market trading, moving lower since Tuesday's close.

27 paź 2026, 23:56 UTC

NextDecade Corporation's shares traded roughly flat during after-market hours on Tuesday, initially showing a slight uptick before retracing to a modest gain.

27 paź 2026, 23:56 UTC

Waters Corp shares traded modestly lower in after-market hours, dipping nearly 1% below Tuesday's close before a slight recovery.

27 paź 2026, 23:56 UTC

Correlated Moves

Modine Manufacturing Company shares are modestly higher in after-market hours, coinciding with a significant rise in Ultra Clean Holdings following strong third-quarter results.

27 paź 2026, 23:56 UTC

Equinix, Inc. shares are modestly higher in after-market trading, continuing a trend of four consecutive sessions of gains amid rising durable goods orders.

27 paź 2026, 23:56 UTC

Lemonade Inc. traded modestly higher during after-market hours on Tuesday, increasing from a low point shortly after the regular session ended.

27 paź 2026, 23:52 UTC

Mexican Business Confidence Survey Set for Release Amid Ongoing Economic Challenges and Mixed Investor Sentiment

27 paź 2026, 23:52 UTC

Brazil's Central Bank faces pressure to maintain SELIC at 13.25% amid market fears of higher borrowing costs post-election, prompting downgrades in financial sector ratings.

27 paź 2026, 23:52 UTC

Australia's Building Permits MoM report on November 2, 2026, expected to reflect cautious market sentiment amid recent volatility and rising borrowing costs.

27 paź 2026, 23:52 UTC

South Korea's S&P Global Manufacturing PMI release on November 2 sparks cautious optimism amid mixed market sentiment and strong GDP growth.

27 paź 2026, 23:52 UTC

News

Morgan Stanley shares rose in after-market trading as the firm was named a lead underwriter for Anthropic's upcoming IPO, alongside Goldman Sachs.

27 paź 2026, 23:51 UTC

Lyft, Inc. shares are modestly higher in after-market trading, peaking before retracing slightly, while remaining above their 20-day moving average.

27 paź 2026, 23:51 UTC

ACCO Brands Corp is advancing in after-market trading, reflecting strength as it trades near the upper end of its one-month range.

27 paź 2026, 23:51 UTC

APTIV PLC shares are trading lower in after-market hours, declining to just below Tuesday's close and positioned below its 20-day moving average.

27 paź 2026, 23:51 UTC

Correlated Moves

Zillow Group, Inc. shares are lower in after-market trading following CoStar Group's $730 million acquisition of Vexcel and disappointing Q4 guidance.

27 paź 2026, 23:51 UTC

Oceaneering International Inc shares declined in after-market trading, continuing a trend from Tuesday's close, amid notable volatility below its 20-day moving average.

27 paź 2026, 23:51 UTC

Match Group, Inc. is rising in after-market trading, advancing significantly since Tuesday's close, despite having closed lower in the previous five sessions.

27 paź 2026, 23:51 UTC

Intuitive Surgical, Inc. shares declined modestly in after-market trading, reversing earlier gains and reflecting a cumulative loss.

27 paź 2026, 23:51 UTC

Correlated Moves

Social Media

AMD shares are modestly higher in after-market hours following its $1 billion investment in Meta's equity offering and deployment of AMD EPYC processors.

27 paź 2026, 23:51 UTC

Altria Group Inc. is trading modestly higher in after-market hours, rebounding after three consecutive sessions of declines while remaining above its 20-day moving average.

27 paź 2026, 23:51 UTC

Roku, Inc. declined during after-market trading, continuing a trend with four consecutive lower finishes since Tuesday's close.

27 paź 2026, 23:51 UTC

Coupang, Inc. is trading modestly lower in after-market hours, dipping below Tuesday's close and remaining significantly below its 20-day moving average.

27 paź 2026, 23:51 UTC

Correlated Moves

Vertiv Holdings Co is higher in after-market hours, following Ultra Clean Holdings Inc's third-quarter results that showed record revenue and earnings exceeding analyst expectations.

27 paź 2026, 23:51 UTC

GE HealthCare Technologies Inc. shares declined modestly in after-market trading, retreating from a brief peak earlier in the session.

27 paź 2026, 23:51 UTC

The Progressive Corporation is trading modestly higher in after-market hours, reaching its highest point since Tuesday's close and remaining above its 20-day moving average.

27 paź 2026, 23:51 UTC

Terex Corporation's shares are declining in after-market trading, reflecting continued weakness and trading well below its 20-day moving average.

27 paź 2026, 23:51 UTC

Wingstop Inc. is trading modestly lower in after-market hours, having shifted from a nearly flat position earlier in the session.

Peer Comparison

Price change

Capricor Therapeutics Inc Forecast

Price Target

By TipRanks

342.62% upside

12 Months Forecast

Average 27 USD 342.62%

High 54 USD

Low 7 USD

Based on 10 Wall Street analysts offering 12 month price targets forCapricor Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

Buy

Hold

Sell

Based on 10 analysts giving stock ratings to Capricor Therapeutics Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Capricor Therapeutics Inc

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment of duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs. The company's lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase 3 clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD). It also focused on developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases. In addition, the company develops CAP-2003, under pre-clinical development for the treatment of trauma related injuries and conditions. It has collaboration and distribution agreement with Nippon Shinyaku Co. Ltd., collaboration agreement with National Institute of Allergy and Infectious Diseases, license agreements with the Johns Hopkins University and Cedars-Sinai Medical Center, as well as cell line license agreement with Life Technologies Corporation. The company was founded in 2005 and is headquartered in San Diego, California.